U.S. markets open in 4 hours 18 minutes
  • S&P Futures

    4,541.75
    +33.25 (+0.74%)
     
  • Dow Futures

    34,323.00
    +321.00 (+0.94%)
     
  • Nasdaq Futures

    15,944.75
    +75.00 (+0.47%)
     
  • Russell 2000 Futures

    2,173.60
    +27.30 (+1.27%)
     
  • Crude Oil

    67.22
    +1.65 (+2.52%)
     
  • Gold

    1,774.30
    -10.00 (-0.56%)
     
  • Silver

    22.38
    +0.04 (+0.16%)
     
  • EUR/USD

    1.1331
    +0.0009 (+0.08%)
     
  • 10-Yr Bond

    1.4340
    0.0000 (0.00%)
     
  • Vix

    28.14
    +0.95 (+3.49%)
     
  • GBP/USD

    1.3317
    +0.0039 (+0.30%)
     
  • USD/JPY

    113.0660
    +0.2860 (+0.25%)
     
  • BTC-USD

    56,709.57
    -396.09 (-0.69%)
     
  • CMC Crypto 200

    1,447.21
    -21.87 (-1.49%)
     
  • FTSE 100

    7,130.02
    -38.66 (-0.54%)
     
  • Nikkei 225

    27,753.37
    -182.25 (-0.65%)
     

Stamps.com Jumps on Shopify Takeover Talk

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

By Christiana Sciaudone

Investing.com -- Stamps (NASDAQ:STMP).com Inc. rose almost 10% Monday after Citron Research said Shopify (NYSE:SHOP) could acquire the internet-based mailing and shipping solutions company.

Shopify is up more than 7%, having more than doubled in 2020.

Citron cites e-commerce being “on fire” and a large valuation gap, and is the “essential tool for small business” that is not owned by Shopify, which supports anyone interested in setting up an online store and selling products.

Shares of Stamps.com have almost tripled in 2020. In May, the company forecast total revenue for the year at between $570 million to $600 million, unchanged from previous guidance, as well as net income between $41 million and $53 million.

Total revenue for the first quarter rose 11% from a year earlier, to $151 million.

Related Articles

Germany stocks higher at close of trade; DAX up 0.99%

France stocks higher at close of trade; CAC 40 up 0.47%

First human trial of Oxford coronavirus vaccine shows promise